Review article: rifabutin in the treatment of refractory Helicobacter pylori infection.
about
Optimum antibiotic doses for Helicobacter pylori eradicationRole of Helicobacter pylori infection in gastric carcinogenesis: Current knowledge and future directionsSecond and third line treatment options for Helicobacter pylori eradicationRescue Therapy with a Proton Pump Inhibitor Plus Amoxicillin and Rifabutin for Helicobacter pylori Infection: A Systematic Review and Meta-AnalysisTreatment of Helicobacter pylori infection: current status and future concepts.Antimicrobial susceptibility of Helicobacter pylori isolates from Lower Silesia, PolandClinical Rationale for Confirmation Testing After Treatment of Helicobacter pylori Infection: Implications of Rising Antibiotic Resistance.Rifabutin-based high-dose proton-pump inhibitor and amoxicillin triple regimen as the rescue treatment for Helicobacter pyloriConnectivity mapping using a combined gene signature from multiple colorectal cancer datasets identified candidate drugs including existing chemotherapiesSmall intestinal bacterial overgrowth and celiac disease: A systematic review with pooled-data analysis.Effectiveness of Second through Sixth Line Salvage Helicobacter pylori Treatment: Bismuth Quadruple Therapy is Almost Always a Reasonable Choice.Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study.Helicobacter pylori therapy: a paradigm shift.Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidenceReview article: the global emergence of Helicobacter pylori antibiotic resistance.Efficacy of Levofloxacin-Based Third-Line Therapy for the Eradication of Helicobacter pylori in Peptic Ulcer Disease.Treatment of Helicobacter pylori infection 2012.Helicobacter pylori eradication in Western Australia using novel quadruple therapy combinations.Current options for the treatment of Helicobacter pylori.Helicobacter pylori resistance rates for levofloxacin, tetracycline and rifabutin among Irish isolates at a reference centre.Helicobacter pylori: future perspectives in therapy reflecting three decades of experience.Attempts to enhance the eradication rate of Helicobacter pylori infectionTreatment of Helicobacter pylori infection: meeting the challenge of antimicrobial resistance.Helicobacter pylori eradication in West Asia: a reviewEfficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: a multicentre clinical trial.Mechanisms of Helicobacter pylori antibiotic resistance and molecular testing.Challenges to the Treatment and New Perspectives for the Eradication of Helicobacter pylori.Eradication of Helicobacter pylori Infection.Rifamycins, Alone and in Combination.A prospective evaluation of levofloxacin-based triple therapy for refractory Helicobacter pylori infection in Australia.Population screening and treatment of Helicobacter pylori infection.Current Paradigm and Future Directions for Treatment of Helicobacter pylori Infection.Helicobacter pylori Eradication Therapies in the Era of Increasing Antibiotic Resistance: A Paradigm Shift to Improved Efficacy.H. pylori Management in ASEAN: the Bangkok Consensus Report.Limited effectiveness with a 10-day bismuth-containing quadruple therapy (Pylera® ) in third-line recue treatment for Helicobacter pylori infection. A real-life multicenter study.Antimicrobial susceptibility testing before first-line treatment for Helicobacter pylori infection in patients with dual or triple antibiotic resistance.Fourth-line rescue therapy with rifabutin in patients with three Helicobacter pylori eradication failures.ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.Rifabutin Containing Triple Therapy and Rifabutin with Bismuth Containing Quadruple Therapy for Third-Line Treatment of Helicobacter pylori Infection: Two Pilot Studies.Three unsuccessful treatments of Helicobacter pylori infection by a highly virulent strain with quadruple antibiotic resistance.
P2860
Q24195105-81BE62BE-4A8D-4F7C-82E5-81379736EC55Q26778023-355B60A4-745C-4159-9FF4-2C89E30C6E75Q26829666-8822D545-70E3-4328-81A3-153B90C9728EQ28085359-8ACBBEF9-1748-4FC5-9F96-39076CB24714Q33594850-BA9E1E9A-B874-493C-9976-9BE2EF30D510Q33935291-8040FA49-34D6-4DCA-92A2-C024D75A952FQ34448307-D66E740C-7A1A-44C7-AD7A-36529850E87BQ34823645-EDE5741D-8C1D-4185-AC51-7F64F7CD7948Q35769403-AF59F2CD-75F2-4690-84D5-B655917494FAQ36278242-A53F2529-FA67-4DAD-907B-0E1CE10D42C7Q36997005-B571F3F3-1C9B-4D90-8F13-C52D225DD412Q37045762-A2951914-DAE9-478A-BD44-A26F464AB462Q37082187-586A2565-23D4-4D2C-8250-306E8ED18A26Q37315773-0D42E095-CB8D-4328-93DE-FD9B0A31866DQ37340339-9CC3C359-7420-4D69-8D19-43D295EEEC05Q37696038-D206012A-04C8-476E-9243-5359A1AA5B09Q38041644-FEF25667-D043-4F1A-9B26-8953F681FB74Q38052634-14FB153E-4ADE-4C9A-A4F3-1F72A32A25E7Q38075061-F1564315-C24F-4C9F-B951-A56206C28CABQ38102589-82C97CFB-4C68-4F24-A01D-6A42DF876D20Q38191566-D47ABF25-591C-4BA8-AF7A-D86E0C97CC16Q38212213-85E1736A-1ABA-4011-87DF-5F1B631263F0Q38238745-E2B4C373-D42A-4E77-A42F-B5A72A6CE817Q38240846-84595596-1413-4072-A251-BF07F0FB5FCEQ38462098-0A281407-CDE2-443F-8E01-F8436DCE9FACQ38490776-38127644-1ED0-42CE-A3C5-C966E1836611Q38496942-007D6536-A300-4F25-91A9-8E83E0FA2EB4Q38833959-708BE7A5-15E1-4333-9EDB-EFFB45430A66Q38857578-812FEB6F-2549-43F4-BF7D-2DF878C7C2DBQ38874731-114067F1-EB41-460A-A445-16A1E666C8B4Q39067619-DD6595BA-2EF5-4A3C-95F3-1EAC48C14118Q39135143-A1731488-0FF7-4A5F-9B18-9E31D57B6AF9Q39588933-32008308-BD58-4F62-B9B2-E64BAE860BAEQ40100019-0C243E14-0197-4951-A541-64A53CC0C932Q40108161-8F518427-39BF-4950-8BB7-8013F405F3F3Q40190155-CF5DA644-F49D-4FF8-81D7-4A9213FE5613Q40294669-551685B2-362A-41A0-B99E-ABA8A994F63AQ40378087-DC790F30-5F1A-4BAF-9895-292FC1E955E0Q40819420-A1D977B1-CA8F-473B-9052-145B2CEA1703Q40883721-EC56FE43-9A56-4546-8789-3C393D8F4A05
P2860
Review article: rifabutin in the treatment of refractory Helicobacter pylori infection.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Review article: rifabutin in the treatment of refractory Helicobacter pylori infection.
@en
Review article: rifabutin in the treatment of refractory Helicobacter pylori infection.
@nl
type
label
Review article: rifabutin in the treatment of refractory Helicobacter pylori infection.
@en
Review article: rifabutin in the treatment of refractory Helicobacter pylori infection.
@nl
prefLabel
Review article: rifabutin in the treatment of refractory Helicobacter pylori infection.
@en
Review article: rifabutin in the treatment of refractory Helicobacter pylori infection.
@nl
P2860
P50
P1476
Review article: rifabutin in the treatment of refractory Helicobacter pylori infection
@en
P2093
P2860
P304
P356
10.1111/J.1365-2036.2011.04937.X
P407
P577
2011-11-30T00:00:00Z